Ambrisentan
Top View
- 2020 Complete Drug List (Formulary)
- NEW--Npf-MASTER LIST.Xlsx
- Brand Generic Guide
- Blue Cross and Blue Shield October 2019 Multi-Tier Basic Drug List I How to Use This List Generic Drugs Are Shown in Lower-Case Boldface Type
- Medicaid Health Plan Common Formulary
- Final Decisions and Reasons for Decisions by Delegates of the Secretary to the Department of Health
- Pulmonary Arterial Hypertension: Role of Ambrisentan
- FEP 5 Tier Rx Drug Formulary (607) Standard Option
- Clinical Trials with Endothelin Receptor Antagonists: What Went Wrong and Where Can We Improve?☆
- Drug Coverage Guidelines – Oxford Clinical Policy
- Endothelin Receptor Antagonists (Eras) Annual Review Date: Tracleer (Bosentan) 1/21/2021 Letairis (Ambrisentan) Opsumit (Macitentan) Last Revised Date: 2/18/2021
- SAFE HANDLING of HAZARDOUS DRUGS Updated 5/22/2020
- Read the Notice
- Clinical Trials with Endothelin Receptor Antagonists: What Went Wrong and Where Can We Improve?☆
- Liver Toxicity of Sitaxentan in Pulmonary Arterial Hypertension
- 2021 Aetna Specialty Drug List
- January 13, 2020
- Preferred Brand Drugs with Non-Preferred Generic Drugs PDL